News

FDA approves PARP-inhibitor for ovarian cancer

Posted on: 19/12/2014 - 18:41

Olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, has been approved for treating advanced ovarian cancer associated with defective BRCA genes, the Food and Drug Administration announced on...

Field of Interest: Oncology
Type: News Item

Psoriasis patients have higher rate of low back pain

Posted on: 18/12/2014 - 18:15

The prevalence of low back pain appears to be higher in people with psoriasis than in the general population, according to an analysis of national survey data. The findings may change the way...

Field of Interest: Dermatology
Type: News Item

Psoriasis patients have higher rate of low back pain

Posted on: 18/12/2014 - 18:15

The prevalence of low back pain appears to be higher in people with psoriasis than in the general population, according to an analysis of national survey data. The findings may change the way...

Field of Interest: Rheumatology
Type: News Item

Preeclampsia in SLE ups CVD risk

Posted on: 18/12/2014 - 18:13

Women with lupus and a history of preeclampsia have almost fourfold higher odds of subsequent heart disease as measured by coronary artery calcium than do women with the disease who never had...

Field of Interest: Rheumatology
Type: News Item

Preeclampsia in SLE ups CVD risk

Posted on: 18/12/2014 - 18:13

Women with lupus and a history of preeclampsia have almost fourfold higher odds of subsequent heart disease as measured by coronary artery calcium than do women with the disease who never had...

Field of Interest: Pulmonology
Type: News Item

Alzheimer’s a winner in federal spending bill

Posted on: 17/12/2014 - 22:25

*Article updated 12/18/14 The massive $1.1 trillion spending bill that was approved by Congress before it left for an extended recess included several provisions aimed at bolstering...

Field of Interest: Geriatrics
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More